Nanalysis establishes science advisory board with four world-renowned scientists


Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) (“Nanalysis” or the “Company”) is pleased to announce that as of December 21, 2021, it has set up a Scientific Advisory Board, made up of four of the world famous scientists as founding members, including Dr Matt Rosen of Harvard Medical School and co-founder of Hyperfine.

Nanalysis is a leader in miniaturized magnetic resonance systems for industrial analysis and has a vision to disrupt the MRI space. In order to complement the vision and capabilities of the Nanalysis R&D team, as well as serve as a resource for Nanalysis senior management, the company has established a formal Scientific Advisory Board, comprised of world-renowned scientists in the fields fields of magnetic resonance and machines. learning. A key aspect of the Company’s vision is to use machine learning and AI to democratize data generated by magnetic resonance machines, both for industrial analysis applications and medical imaging applications. .

Sean krakiwsky , Founder and CEO of Nanalysis says, “It is important for our company to stay connected to important initiatives of the global scientific community. Establishing this Scientific Advisory Board as a tentacle in the global innovation community is important to Nanalysis, as is our serving on standard committees, attending conferences and attracting top talent to our leadership team and board. administration. We must always remain active in the market for ideas and avoid any bias towards inner thinking. We are delighted that these first members are joining our scientific team. Advisory Board and contributing to our grand vision as we continue to democratize Magnetic Resonance. ”

Julien muller , CTO of Nanalysis says, “I have had extensive scientific interaction with the members of our Scientific Advisory Board for many years, and can attest to their very deep and diverse knowledge in various fields of magnetic resonance, both in research and application. careers, they have also developed enormous knowledge about what the market wants in terms of business offerings. I look forward to working with them all and ensuring that Nanalysis remains at the forefront of Magnetic Resonance, as we continue to strengthen our technology base, on which we aggressively drive towards our vision! ”

Nanalysis will add and evolve its Scientific Advisory Board over time to increase the company’s R&D and go-to-market capabilities. Nanalysis is committed to making a positive contribution to the global scientific community. The company web page for this advisory board is

The members of the Scientific Council are as follows:

Dr. Matt Rosen , Harvard Medical School : Matt is a physicist, tool builder and inventor whose research connects the spectrum of fundamental physics with applied bioimaging work in the field of MRI. He has built his career around his ability to identify global needs and respond to them with creative solutions that span academic disciplines and push the boundaries of innovation. He is the Director of the Low Field MRI and Hyperpolarized Media Laboratory at the Biomedical Imaging Center of the Martinos General Mass Hospital. His research group at Mass General Hospital and Harvard focuses on new methods and tools to enable unconventional approaches to the construction of MRI scanners. This includes the development of novel acquisition strategies for robust ultra-low magnetic field MRI implementations focused on brain imaging. He founded five companies: Hyperfine Research, BlinkAI Technologies, Vizma Life Sciences, Intact Data Services and Q4ML. He is the inventor of more than 25 issued patents. His groups website is .

Dr Piotr Starewiz, CEO of Resonance Research Inc. (RRI): Dr Starewicz has over 35 years of experience in magnetic resonance hardware, software and algorithms. His company has supplied key technology modules to the world’s largest MRI and NMR companies for three decades. His post-graduate career began when he joined Siemens Medical Systems in 1984, where he served as Director of R&D in Magnetic Resonance. Recognizing early on that MRI required a much better level of support than other diagnostic modalities, Dr Starewicz created the Applications Science group at Siemens, which led to the adoption of MRI through enhanced training for doctors and technicians. These two founding groups of Siemens were largely responsible for the enormous commercial success of MRI machines in the era of 1.0 T and 1.5 T scanners: sales of these models reached 750 units / year in the early 90s, catapulting Siemens into a leading position in MRI. In 1988 he founded RRI, a company that has grown into a recognized leader in magnetism and electronics for MRI and NMR systems, including human systems up to 10.5 T and preclinical systems. (animals) up to 21 T. During his career, Dr. Starewicz has published in peer-reviewed journals and has several US and international patents to his credit. He has a B.Sc. from Imperial College London, a doctorate. from University of Wisconsin , and his post-doctoral work was carried out at MIT . RRI’s website is .

Dr. Len mueller , president and professor of chemistry at the University of california , Riverside: Len received his bachelor’s degree in chemistry from Rochester University (1988), CPGS in natural sciences (chemistry) of the Cambridge University (1989) and Ph.D. in chemistry of California Institute of Technology (1997). From 1996 to 1998, he was the American Cancer Society Postdoctoral Fellow at the Massachusetts Institute of Technology. Len’s research interests include nuclear magnetic resonance spectroscopy as a probe of molecular and biological structure and dynamics. His group pioneered techniques for improving sensitivity and resolution in NMR spectroscopy and pioneered the development of integrated techniques in magnetic resonance. While nuclear magnetic resonance, with a particular affinity for solid state NMR, is the centerpiece of his work, he also makes extensive use of the first principles of computational chemistry and crystallography, and a theme under – Underlying his group’s work is how NMR fits into a larger framework. to construct and quantitatively test chemically detailed models of chemical and conformational structure and dynamics. The site of his group is: .

Dr. Dimitrios Sakellariou , professor at KU Leuven: Dimitrios group develops and applies magnetic resonance in advanced materials and chemical / biomedical processes, especially in the fields of membrane separation, adsorption, catalysis and spectroscopy for sustainable solutions (cMACS). Before his current appointment, he worked as a principal researcher, principal expert at the Commissariat à l’énergie atomique (CEA-Saclay). His expertise and interests in the field of magnetic resonance range from nuclear magnetic resonance (NMR) spectroscopy and high field imaging (MRI) to benchtop instrumentation applied industrially to measure. He received an ERC Seed Fellowship in 2008 for the development of the first preclinical rotating field MRI scanner and the Borgia Award for “For Outstanding Leadership in the Development of NMR Techniques” in 2004. He is the founder of The RE Magnet Studio Ltd. ., co-author of more than 95 publications and co-inventor of more than 13 patents and applications. His group’s website is .

About Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with the symbol ‘NSCI’, OTC and the Frankfurt trades under the ticker symbol “1N1”. The business of the company is what we call “MRI and NMR for industry”. The company develops and manufactures portable nuclear magnetic resonance (NMR) spectrometers or analyzers for the laboratory and industrial markets. The NMReady-60 ™ was the first portable NMR spectrometer complete in a single compact enclosure requiring no liquid helium or other cryogens. The company has continued this initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it began selling a 100 MHz device in 2020. The company’s new device will be the most powerful and advanced compact NMR device ever to hit the market.

Analytical devices are used in many industries (oil and gas, chemicals, mining, pharmaceuticals, biotechnology, flavors and fragrances, agrochemicals, law enforcement, etc.) as well as in many government research laboratories and academics around the world. The company continues to exploit new opportunities in the global market independently and with partners.

Notice regarding forward-looking statements and legal notices

This press release contains certain “forward-looking statements” within the meaning of such statements under applicable securities laws. Forward-looking statements are frequently characterized by words such as “anticipate”, “continue”, “estimate”, “expect”, “could”, “could” occur. These statements are only predictions of what we think may happen. Various assumptions have been used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to various risks and uncertainties and other factors that could cause actual events or results to differ. substantially from those projected in the forward forecast. staring statements. The Company has no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:

SOURCENanalysis Scientific Corp.

Cision View original content to download multimedia:


About Author

Comments are closed.